Nektar Therapeutics (NKTR) Revenue (2010 - 2026)
Nektar Therapeutics' Revenue was $10.13 million in Q2 2026, down 9.3% from $11.18 million a year earlier and down 6.7% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Revenue (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Nektar Therapeutics' Revenue was $54.59 million through Jun 30, 2026, down 27.2% year-over-year; for FY2025, it was $55.23 million, down 43.9% from FY2024.
- Revenue shows a five-year compound annual growth rate of -18.4% (FY2020 to FY2025).
- In earlier years, Revenue was $98.43 million in FY2024 (+9.2%), $90.12 million in FY2023 (-2.1%), $92.06 million in FY2022 (-9.7%) and $101.91 million in FY2021 (-33.4%).
- The Q2 2026 figure marks the lowest quarterly Revenue in data going back to Q1 2010.
- Compared with a year earlier, Revenue was higher in two of the last eight quarters, with an average decline of 20.5%.
- The best year-over-year quarter for Revenue over five years was Q4 2024 (growth of 22.1%); the worst was Q2 2025 (a decline of 52.4%).
- Per Business Quant data, NKTR's Revenue in the three quarters before Q2 2026 was $10.86 million (Q1 2026), $21.81 million (Q4 2025) and $11.79 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Nektar Therapeutics | 2.00 Bn | 227.61 Mn | - | 10.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.13 Mn |
| Mar 31, 2026 | 10.86 Mn |
| Dec 31, 2025 | 21.81 Mn |
| Sep 30, 2025 | 11.79 Mn |
| Jun 30, 2025 | 11.18 Mn |
| Mar 31, 2025 | 10.46 Mn |
| Dec 31, 2024 | 29.18 Mn |
| Sep 30, 2024 | 24.12 Mn |
| Jun 30, 2024 | 23.49 Mn |
| Mar 31, 2024 | 21.64 Mn |
| Dec 31, 2023 | 23.89 Mn |
| Sep 30, 2023 | 24.14 Mn |
| Jun 30, 2023 | 20.50 Mn |
| Mar 31, 2023 | 21.59 Mn |
| Dec 31, 2022 | 22.02 Mn |
| Sep 30, 2022 | 23.63 Mn |
| Jun 30, 2022 | 21.59 Mn |
| Mar 31, 2022 | 24.82 Mn |
| Dec 31, 2021 | 25.01 Mn |
| Sep 30, 2021 | 24.92 Mn |
API Access
Nektar Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();